Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?

Guardado en:
Detalles Bibliográficos
Autores principales: Zoe Apalla, Eftychios Psarakis, Aimilios Lallas, Alexia Koukouthaki, Athanassios Fassas, Maria Smaragdi
Formato: article
Lenguaje:EN
Publicado: Mattioli1885 2019
Materias:
Acceso en línea:https://doaj.org/article/a5f7175648b64ccf951595665b8ec48b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a5f7175648b64ccf951595665b8ec48b
record_format dspace
spelling oai:doaj.org-article:a5f7175648b64ccf951595665b8ec48b2021-11-17T08:29:13ZPsoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?10.5826/dpc.0904a112160-9381https://doaj.org/article/a5f7175648b64ccf951595665b8ec48b2019-10-01T00:00:00Zhttp://dpcj.org/index.php/dpc/article/view/688https://doaj.org/toc/2160-9381Zoe ApallaEftychios PsarakisAimilios LallasAlexia KoukouthakiAthanassios FassasMaria SmaragdiMattioli1885articlepsoriasisadenocarcinomaapremilastphosphodiesterase inhibitortreatmentDermatologyRL1-803ENDermatology Practical & Conceptual, Vol 9, Iss 4 (2019)
institution DOAJ
collection DOAJ
language EN
topic psoriasis
adenocarcinoma
apremilast
phosphodiesterase inhibitor
treatment
Dermatology
RL1-803
spellingShingle psoriasis
adenocarcinoma
apremilast
phosphodiesterase inhibitor
treatment
Dermatology
RL1-803
Zoe Apalla
Eftychios Psarakis
Aimilios Lallas
Alexia Koukouthaki
Athanassios Fassas
Maria Smaragdi
Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
format article
author Zoe Apalla
Eftychios Psarakis
Aimilios Lallas
Alexia Koukouthaki
Athanassios Fassas
Maria Smaragdi
author_facet Zoe Apalla
Eftychios Psarakis
Aimilios Lallas
Alexia Koukouthaki
Athanassios Fassas
Maria Smaragdi
author_sort Zoe Apalla
title Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
title_short Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
title_full Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
title_fullStr Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
title_full_unstemmed Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
title_sort psoriasis in patients with active lung cancer: is apremilast a safe option?
publisher Mattioli1885
publishDate 2019
url https://doaj.org/article/a5f7175648b64ccf951595665b8ec48b
work_keys_str_mv AT zoeapalla psoriasisinpatientswithactivelungcancerisapremilastasafeoption
AT eftychiospsarakis psoriasisinpatientswithactivelungcancerisapremilastasafeoption
AT aimilioslallas psoriasisinpatientswithactivelungcancerisapremilastasafeoption
AT alexiakoukouthaki psoriasisinpatientswithactivelungcancerisapremilastasafeoption
AT athanassiosfassas psoriasisinpatientswithactivelungcancerisapremilastasafeoption
AT mariasmaragdi psoriasisinpatientswithactivelungcancerisapremilastasafeoption
_version_ 1718425816444960768